Back to AVBP
BARCLAYS PLC AVBP Position History
ArriVent BioPharma, Inc. • Healthcare
Quarters held
24
Latest value
$124K
Q3 2026
Peak value
$2.6M
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $125K |
| Q1 2024 | $129K |
| Q2 2024 | $63K |
| Q3 2024 | $976K |
| Q4 2024 | $1.4M |
| Q1 2025 | $742K |
| Q1 2025 | $9K |
| Q2 2025 | $2.5M |
| Q2 2025 | $63K |
| Q2 2025 | $218 |
| Q3 2025 | $2.4M |
| Q3 2025 | $185 |
| Q3 2025 | $976K |
| Q3 2025 | $2.4M |
| Q3 2025 | $185 |
| Q4 2025 | $2.6M |
| Q4 2025 | $201 |
| Q1 2026 | $1.5M |
| Q1 2026 | $10K |
| Q1 2026 | $231 |
| Q2 2026 | $2.4M |
| Q2 2026 | $103K |
| Q3 2026 | $2.5M |
| Q3 2026 | $124K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $124K | 4.1K | — | — |
| Q3 2026 | $2.5M | 82.5K | — | — |
| Q2 2026 | $103K | 3.0K | — | — |
| Q2 2026 | $2.4M | 68.0K | — | — |
| Q1 2026 | $231 | 10 | — | — |
| Q1 2026 | $10K | 431 | — | — |
| Q1 2026 | $1.5M | 65.0K | — | — |
| Q4 2025 | $201 | 10 | — | — |
| Q4 2025 | $2.6M | 129.2K | — | — |
| Q3 2025 | $185 | 10 | — | — |
| Q3 2025 | $2.4M | 129.9K | — | — |
| Q3 2025 | $976K | 41.5K | — | — |
| Q3 2025 | $185 | 10 | — | — |
| Q3 2025 | $2.4M | 129.9K | — | — |
| Q2 2025 | $218 | 10 | — | — |
| Q2 2025 | $63K | 2.9K | — | — |
| Q2 2025 | $2.5M | 114.3K | — | — |
| Q1 2025 | $9K | 467 | — | — |
| Q1 2025 | $742K | 40.1K | — | — |
| Q4 2024 | $1.4M | 53.5K | — | — |
| Q3 2024 | $976K | 41.5K | — | — |
| Q2 2024 | $63K | 3.4K | — | — |
| Q1 2024 | $129K | 7.2K | — | — |
| Q1 2024 | $125K | 7.0K | — | — |
Other funds holding AVBP
$80.9M
$70M
$65.5M
$62.1M
$59.2M
$58.8M